Teladoc Health Q2 Earnings Beat Estimates with $631.9M Revenue and -$0.19 EPS

Teladoc Health reported Q2 GAAP EPS of -$0.19, beating expectations by $0.07. Revenue of $631.9M (-1.6% Y/Y) also beat expectations by $9.1M. Q3 and FY25 revenue and EPS consensus estimates were $628.49M and -$0.24, and $2.52B and -$1.16, respectively.

Teladoc Health Inc. (NYSE: TDOC) reported its Q2 2025 financial results, with GAAP EPS of -$0.19, beating expectations by $0.07. Revenue of $631.9M (-1.6% Y/Y) also exceeded estimates by $9.1M. The company's 3Q25 revenue and EPS consensus estimates were $628.49M and -$0.24, respectively, while the full-year 2025 revenue and EPS consensus estimates were $2.52B and -$1.16, respectively [1].

The company expects 3Q2025 revenue to range between $614 million and $636 million, with adjusted EBITDA expected to be between $56 million and $70 million. The net loss per share is forecasted to be between $0.35 and $0.20. For the full year of 2025, Teladoc Health expects revenue to be between $2.51 billion and $2.548 billion, with adjusted EBITDA expected to be between $263 million and $294 million. The net loss per share is projected to be between $1.35 and $1.00, while free cash flow is expected to be between $170 million and $200 million [1].

Teladoc Health's stock performance on July 30, 2025, saw a slight decrease, with the stock trading at $7.80, down from the previous close of $8.20. The stock has seen significant volatility, with a 52-week low of $6.35 and a 52-week high of $15.21. Over the past year, the stock has returned -14.42% compared to the sector index, which has returned -9.8% [2].

Analysts have a mixed view on Teladoc Health, with 31% recommending a buy, 68% holding, and 0% selling. The average target price is $9.16, representing an upside of 17.47% compared to the current price of $7.80. The stock's market capitalization is $1.4 billion, with a P/E ratio of 8.14 and a profit margin of -39.66% [2].

References:
[1] https://seekingalpha.com/news/4473770-teladoc-health-gaap-eps-of-0_19-beats-by-0_07-revenue-of-631_9m-beats-by-9_1m
[2] https://www.indmoney.com/us-stocks/teladoc-inc-share-price-tdoc